Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma

BACKGROUND: Despite aggressive multimodal treatments the overall survival of patients with high-risk neuroblastoma remains poor. The aim of this study was to identify novel combination chemotherapy to improve survival rate in patients with high-risk neuroblastoma. METHODS: We took a synthetic lethal...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, Patricia S, Cheuk, Adam T, Chen, Qing-Rong, Song, Young K, Badgett, Thomas C, Wei, Jun S, Khan, Javed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364855/
https://www.ncbi.nlm.nih.gov/pubmed/22436457
http://dx.doi.org/10.1186/1471-2407-12-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364855/
https://www.ncbi.nlm.nih.gov/pubmed/22436457
http://dx.doi.org/10.1186/1471-2407-12-101

Ejemplares similares